\
&
Contact us
\
&
Contact us
Starts in 1 day from now
LocationBrussels
HERA Industry Days are dedicated to shaping the future of medical countermeasures (MCMs). The event will bring together industry leaders, innovators, policymakers, and technical experts. It aims to foster strategic partnerships, unlock key insights into the Commission's Health Emergency preparedness and Response Authority (HERA) and the EU’s priorities, and enhance industry engagement — especially for SMEs and start-ups.
Several plenary panels are on the HERA Industry Day's agenda:
More information and registration on the event webpage.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Climate, Energy, Mobility EIC EIE
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
